<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/59F09DF9-DD13-4FFB-9429-2993C1DD4F54"><gtr:id>59F09DF9-DD13-4FFB-9429-2993C1DD4F54</gtr:id><gtr:name>MRC Human Reproductive Sciences Unit</gtr:name><gtr:address><gtr:line1>Centre for Reproductive Biology</gtr:line1><gtr:line2>37 Chalmers Street</gtr:line2><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH3 9EW</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/59F09DF9-DD13-4FFB-9429-2993C1DD4F54"><gtr:id>59F09DF9-DD13-4FFB-9429-2993C1DD4F54</gtr:id><gtr:name>MRC Human Reproductive Sciences Unit</gtr:name><gtr:address><gtr:line1>Centre for Reproductive Biology</gtr:line1><gtr:line2>37 Chalmers Street</gtr:line2><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH3 9EW</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/C80D6495-9BA2-4627-9C93-034D2F62AAE7"><gtr:id>C80D6495-9BA2-4627-9C93-034D2F62AAE7</gtr:id><gtr:firstName>Hamish</gtr:firstName><gtr:surname>Fraser</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U127684437"><gtr:id>AF38D081-D7BA-40B2-B604-78A88A387347</gtr:id><gtr:title>Regulation of angiogenesis and endothelial cell function</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U127684437</gtr:grantReference><gtr:abstractText>Angiogenesis is the development of new blood vessels from pre-existing capillaries by multiplication of endothelial cells lining the vessels. In the adult, stability of the microvasculature is such that angiogenesis is rare. One exception is during the development of the ovarian follicle, where there is intense angiogenesis around the follicular wall, associated with alterations in the permeability (leakiness) of the capillaries to nourish the egg contained in the follicle. Several growth factors regulating angiogenesis have been discovered and compounds developed to either increase or reduce angiogenesis. |Isolated follicles in vitro are being used to quatify their abiilty to grow blood vessels and determine how this responds to a variety of possible inhibitors. This allows us to determine how important each factor is and select the most interesting for investigation in vivo. It is probable that in some types of female infertility the underlying cause is some disturbance of follicular angiogenesis resulting in inadequate development: on the other hand in polycystic ovarian syndrome (characterised by development of large numbers of follicles which fail to shed their egg), there is excessive angiogenesis and disturbances in capillary permeability.</gtr:abstractText><gtr:technicalSummary>Follicular development is associated with angiogenesis and increased permeability of follicular blood vessels under the control of locally-produced factors. The on-going development of specific agonists or antagonists to angiogenic factors provides tools to elucidate their physiological role and develop novel strategies to either promote or inhibit follicle development and ovulation. We have escribed the expression of the principal angiogenic factor, vascular endothelial growth factor (VEGF) and its receptors in the ovary, and the effects of in vivo administration of a high affinity blocker (VEGF Trap) on follicular angiogenesis at a cellular and molecular level in the marmoset monkey and on pituitary-ovarian function in the stump tailed macaque. |After quantifying changes in angiogenesis during each stage of follicular development in the marmoset, we investigated the functional role of VEGF in these events. A VEGF inhibitor (VEGF Trap) administered throughout the follicular phase of the cycle resulted in a inhibition of endothelial cell proliferation in developing antral follicles, accompanied by a decline in granulosa cell proliferation, restriction of follicular growth and inhibition of ovulation. In macaques, a single injection of VEGF Trap during the follicular phase resulted in a rapid suppression of serum oestradiol concentrations and inhibition of ovulation. |These data demonstrate that VEGF is essential for normal follicular angiogenesis and function. VEGF Trap is a potent tool for investigating the role of VEGF within the ovary and may have applications to the treatment of reproductive disorders characterised by alterations in normal vascular structure or function such as polycystic ovarina syndrome and endometriosis. |Future objectives aim to test the hypotheses that 1) co-ordinated regulation of the ovarian vasculature is essential for follicular development from primordial follicle to ovulation, 2) differential regulation of vascular permeability influences follicle selection and dominance, 3) manipulation of angiogenic factors can lead to an improved approach to the clinical management of follicular function and 4) increased ovarian targeting of angiogenesis can be achieved by manipulating ovarian-specific angiogenic factors or by developing ultra sound-guided release. We are also developing an in vitro system for studying follicular angiogenesis which should enable the effects of putative pro- or anti-angiogenic factors to be evaluated prior to selection for in vivo studies.</gtr:technicalSummary><gtr:fund><gtr:end>2011-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>1996-01-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>2017365</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>E1B4CCC2-D9E4-4EFC-AFF5-CF44862350C9</gtr:id><gtr:title>Expression of anti-Mullerian hormone protein during early follicular development in the primate ovary in vivo is influenced by suppression of gonadotropin secretion and inhibition of vascular endothelial growth factor.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f94366a81615509f2bf9c99866c2bcd1"><gtr:id>f94366a81615509f2bf9c99866c2bcd1</gtr:id><gtr:otherNames>Thomas FH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>1AE2A99D3A5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>935C3782-B432-4E8B-ADCF-E3452D15A0A3</gtr:id><gtr:title>Identification of androgen receptor phosphorylation in the primate ovary in vivo.</gtr:title><gtr:parentPublicationTitle>Reproduction (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c9b39cf2e5bcca233c944124cb8a1f7f"><gtr:id>c9b39cf2e5bcca233c944124cb8a1f7f</gtr:id><gtr:otherNames>McEwan IJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1470-1626</gtr:issn><gtr:outcomeId>Dkvq5FVPH8r</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8080EB67-D88B-449B-98BB-45F1DED133A0</gtr:id><gtr:title>Thrombospondin-1 expression is increased during follicular atresia in the primate ovary.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f94366a81615509f2bf9c99866c2bcd1"><gtr:id>f94366a81615509f2bf9c99866c2bcd1</gtr:id><gtr:otherNames>Thomas FH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>C0FEC27E8B2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>115BEEF8-8036-40C1-9619-E682F9C081ED</gtr:id><gtr:title>Effects of inhibition of vascular endothelial growth factor at time of selection on follicular angiogenesis, expansion, development and atresia in the marmoset.</gtr:title><gtr:parentPublicationTitle>Molecular human reproduction</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1c1376e065890dcbe4ffb069f21ccbfa"><gtr:id>1c1376e065890dcbe4ffb069f21ccbfa</gtr:id><gtr:otherNames>Taylor PD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1360-9947</gtr:issn><gtr:outcomeId>D0B7D9104C5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>45176FCA-B98A-4E1B-9B5B-9880B01B032C</gtr:id><gtr:title>Thrombospondin-1 Inhibits Angiogenesis and Promotes Follicular Atresia in a Novel
 
 Angiogenesis Assay</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/860f1ea398bca06bd84017dd3f5e2637"><gtr:id>860f1ea398bca06bd84017dd3f5e2637</gtr:id><gtr:otherNames>Garside S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>KmEaQJciNgR</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>086F9559-7F73-4F5B-AD0E-1DDE16AB7AB2</gtr:id><gtr:title>A thrombospondin-mimetic peptide, ABT-898, suppresses angiogenesis and promotes follicular atresia in pre- and early-antral follicles in vivo.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3149cf63a01b68a4d98df3a7e301ba12"><gtr:id>3149cf63a01b68a4d98df3a7e301ba12</gtr:id><gtr:otherNames>Garside SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>Pyj6aeTSgkb</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U127684437</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>FA7AA693-7EDD-4A7E-8CA3-6B5658FBF717</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Reproductive Health and Childbirth</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>